Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Hair growth phase in mice weakens certain immune responses.

ILC1-like cells can independently cause alopecia areata.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

More research is needed to understand and treat cicatricial alopecias.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata is an autoimmune hair loss condition linked to genetic factors.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Inflammation damages sweat ducts, causing sweat gland injury.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Permanent hair dye may cause total hair loss.

Hair loss treatment caused more hair loss in a man.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.